Sorrento Therapeutics (SRNE) Competitors $0.0067 +0.01 (+509.09%) As of 05/21/2025 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsSustainabilityTrendsBuy This Stock SRNE vs. ONCO, CMND, SONN, LIXT, ADIL, CANF, OGEN, SPRC, MBIO, and GLTOShould you be buying Sorrento Therapeutics stock or one of its competitors? The main competitors of Sorrento Therapeutics include Onconetix (ONCO), Clearmind Medicine (CMND), Sonnet BioTherapeutics (SONN), Lixte Biotechnology (LIXT), Adial Pharmaceuticals (ADIL), Can-Fite BioPharma (CANF), Oragenics (OGEN), SciSparc (SPRC), Mustang Bio (MBIO), and Galecto (GLTO). These companies are all part of the "pharmaceutical products" industry. Sorrento Therapeutics vs. Onconetix Clearmind Medicine Sonnet BioTherapeutics Lixte Biotechnology Adial Pharmaceuticals Can-Fite BioPharma Oragenics SciSparc Mustang Bio Galecto Sorrento Therapeutics (NASDAQ:SRNE) and Onconetix (NASDAQ:ONCO) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, community ranking, risk, media sentiment, dividends, institutional ownership, analyst recommendations, profitability and earnings. Which has stronger earnings and valuation, SRNE or ONCO? Onconetix has lower revenue, but higher earnings than Sorrento Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSorrento Therapeutics$60.32M0.06-$572.84MN/AN/AOnconetix$1.87M2.86-$37.41MN/AN/A Does the media prefer SRNE or ONCO? In the previous week, Sorrento Therapeutics' average media sentiment score of 0.00 equaled Onconetix'saverage media sentiment score. Company Overall Sentiment Sorrento Therapeutics Neutral Onconetix Neutral Which has more volatility & risk, SRNE or ONCO? Sorrento Therapeutics has a beta of 1.13, meaning that its stock price is 13% more volatile than the S&P 500. Comparatively, Onconetix has a beta of 3.49, meaning that its stock price is 249% more volatile than the S&P 500. Do institutionals and insiders hold more shares of SRNE or ONCO? 0.0% of Sorrento Therapeutics shares are owned by institutional investors. Comparatively, 23.9% of Onconetix shares are owned by institutional investors. 2.6% of Sorrento Therapeutics shares are owned by company insiders. Comparatively, 3.1% of Onconetix shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Does the MarketBeat Community believe in SRNE or ONCO? Sorrento Therapeutics received 610 more outperform votes than Onconetix when rated by MarketBeat users. CompanyUnderperformOutperformSorrento TherapeuticsOutperform Votes61067.33% Underperform Votes29632.67% OnconetixN/AN/A Is SRNE or ONCO more profitable? Sorrento Therapeutics has a net margin of 0.00% compared to Onconetix's net margin of -2,758.89%. Company Net Margins Return on Equity Return on Assets Sorrento TherapeuticsN/A N/A N/A Onconetix -2,758.89%N/A -48.09% SummaryOnconetix beats Sorrento Therapeutics on 5 of the 9 factors compared between the two stocks. Get Sorrento Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SRNE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SRNE vs. The Competition Export to ExcelMetricSorrento TherapeuticsBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.69M$2.93B$5.38B$8.39BDividend YieldN/A1.71%5.21%4.10%P/E RatioN/A30.5026.8019.71Price / Sales0.06400.15389.70117.54Price / CashN/A168.6838.2534.62Price / BookN/A3.286.804.50Net Income-$572.84M-$72.17M$3.23B$248.18M7 Day PerformanceN/A2.96%1.52%0.23%1 Month PerformanceN/A3.25%10.04%12.39%1 Year PerformanceN/A-28.29%16.73%7.07% Sorrento Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SRNESorrento TherapeuticsN/A$0.01+509.1%N/A-48.5%$3.69M$60.32M0.00800ONCOOnconetix0.0613 of 5 stars$0.07-2.8%N/A-98.4%$4.52M$1.87M0.0012Positive NewsGap UpCMNDClearmind Medicine0.1303 of 5 stars$0.99+2.2%N/A-16.7%$4.21MN/A-0.53N/APositive NewsGap UpSONNSonnet BioTherapeutics2.0538 of 5 stars$1.33+3.9%$20.00+1,403.8%-27.3%$4.08M$1M0.0010LIXTLixte Biotechnology0.3237 of 5 stars$1.28+5.3%N/A-47.2%$4.03MN/A-0.744Positive NewsGap UpADILAdial Pharmaceuticals3.275 of 5 stars$0.61+1.6%$8.00+1,209.3%-49.2%$4.02MN/A-0.1820Analyst RevisionCANFCan-Fite BioPharmaN/A$1.10-0.9%$14.00+1,172.7%-57.7%$3.89M$674,000.00-0.618OGENOragenicsN/A$0.18+6.8%N/A-93.7%$3.87M$40,000.00-0.035SPRCSciSparc0.6216 of 5 stars$0.35+2.3%N/A-75.0%$3.81M$1.31M0.004MBIOMustang Bio0.3652 of 5 stars$1.13-3.0%$100.00+8,749.6%-92.3%$3.74MN/A-0.01100Positive NewsGap DownGLTOGalecto1.6525 of 5 stars$2.78+1.3%$10.00+260.4%-80.9%$3.67MN/A-0.1440Gap Down Related Companies and Tools Related Companies Onconetix Competitors Clearmind Medicine Competitors Sonnet BioTherapeutics Competitors Lixte Biotechnology Competitors Adial Pharmaceuticals Competitors Can-Fite BioPharma Competitors Oragenics Competitors SciSparc Competitors Mustang Bio Competitors Galecto Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SRNE) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredTrump + Musk = AI’s turning pointTrump may not code… but he knows how to pick winners. And according to insiders, his administration is prep...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sorrento Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sorrento Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SRNE Stock Free SRNE Stock Alerts